DE
BIIB icon

DV Equities’s Biogen BIIB Stock Holding History

DV Equities’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$36.1K Buy
+205
New +$33.5K 0.01% 425

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DV Equities's BIIB Position: Q4 2025 in Review

DV Equities opened a new position in Biogen (BIIB) in Q4 2025: 205 shares worth $36.1K. The stake represents 0.01% of the portfolio and ranks #425 among its holdings.

1,000 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.

  • DV Equities held 205 shares of Biogen worth $36.1K as of Q4 2025.
  • Biogen was a new DV Equities position in Q4 2025.
  • Biogen made up 0.01% of DV Equities's portfolio in Q4 2025, its #425 holding.
  • 1,000 funds tracked by Wall St. Rank held Biogen as of Q4 2025.

Based on DV Equities's 13F filing for Q4 2025, filed 17 Feb 2026.